Ocular Therapeutix gets subpoena from SEC over eye pain drug
(Reuters) - Ocular Therapeutix Inc said on Friday the U.S. Securities and Exchange Commission (SEC) had issued a subpoena seeking information about the company's eye-pain drug Dextenza.
from Reuters: Health News http://reut.rs/2CYEweI
http://bit.ly/2zwRqiM